Speaker: Dr. Shireen Sirhan – Hematologist/Oncologist, Jewish General Hospital. Assistant Professor, Dept. of Oncology, McGill University

This webinar will provide an update on the key clinic trials in MPNs including those presented at ASH 2022

At the end of this session, participants will be able to:
-Recognize the unmet needs in the treatment of MPNs
-Identify the ongoing clinical trials in the field of MPNs
-Reflect on the future landscape of treatment of MPNs

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours.

Conflict of Interest: Membership on Advisory Boards/Speakers’ Bureau: GSK, Novartis, BMS, Morphosys, PharmaEssentia, Abbvie
Grants/Clinical Trials: Morphysys, PharmaEssentia, BMS

This webinar was co-developed with Merck and CHS and was planned to achieve scientific integrity, objectivity and balance.

This webinar is offered free of charge to CHS Members.